Amalgamated Bank Has $4.51 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Amalgamated Bank reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 172,891 shares of the pharmacy operator’s stock after selling 9,499 shares during the period. Amalgamated Bank’s holdings in Walgreens Boots Alliance were worth $4,514,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Highlander Capital Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Venturi Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the last quarter. Rocky Mountain Advisers LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter valued at $30,000. Finally, Planned Solutions Inc. bought a new position in Walgreens Boots Alliance in the 4th quarter valued at $34,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research reports. SVB Leerink lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Finally, UBS Group decreased their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $17.35 on Wednesday. The firm’s 50 day simple moving average is $19.43 and its 200 day simple moving average is $21.53. Walgreens Boots Alliance, Inc. has a fifty-two week low of $17.24 and a fifty-two week high of $32.89. The company has a market capitalization of $14.97 billion, a price-to-earnings ratio of -2.48, a P/E/G ratio of 1.10 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the business posted $1.16 earnings per share. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 5.76%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -14.29%.

Insider Transactions at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction dated Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares in the company, valued at $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.